“Candy wrapper” effect after drug‐eluting stent implantation: Déjà vu or stumbling over the same stone again?
- 19 February 2004
- journal article
- case report
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 61 (3) , 387-391
- https://doi.org/10.1002/ccd.10765
Abstract
Encouraging results have been obtained with drug‐eluting stents (DESs) to prevent restenosis following PCI. However, DESs are not immune from restenosis and we describe a case of “candy wrapper” effect, commonly observed with intracoronary brachytherapy (IBT). In this article, we review the common drawbacks of DES and IBT and their prevention. Catheter Cardiovasc Interv 2004;61:387–391.Keywords
This publication has 12 references indexed in Scilit:
- TAXUS III TrialCirculation, 2003
- 7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal GrowthCirculation, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Prolonged Antiplatelet Therapy to Prevent Late Thrombosis After Intracoronary γ-Radiation in Patients With In-Stent RestenosisCirculation, 2001
- Endoluminal Beta-Radiation Therapy for the Prevention of Coronary Restenosis after Balloon AngioplastyNew England Journal of Medicine, 2001
- Geographic MissCirculation, 2000
- Short- and Intermediate-Term Results of 32 P Radioactive β-Emitting Stent Implantation in Patients With Coronary Artery DiseaseCirculation, 2000
- Late Coronary Occlusion After Intracoronary BrachytherapyCirculation, 1999
- Catheter-Based Radiotherapy to Inhibit Restenosis after Coronary StentingNew England Journal of Medicine, 1997
- Intravascular Ultrasound to Discern Device-Specific Effects and Mechanisms of RestenosisThe American Journal of Cardiology, 1996